Pala-Tech Vitamin K1 25mg Chewable Tablets For Dogs & Cats
Phytonadione
Pala-Tech Vitamin K1 Chewable
Tablets is indicated in dogs & cats to counter hypoprothrombinemia induced by
ingestion of coumarin-based compounds, common ingredients of commercial
rodenticides, and other drug induced hypoprothrombinemia where it is
definitely shown that the result is due to interference with vitamin K
metabolism, i.e. salicylates.
Dosage for Dogs & Cats: Acute
hypoprothrombinemia (with hemorrhage) - Administer orally at the rate of
2.5 - 5.0 mg/kg body weight (1 chewable tablet per each 22 pounds of
body weight for lower dosage or 1 chewable tablet per each 11 pounds for
higher dosage) daily as conditions require up to three weeks. Frequency
and amount of oral administration should be guided by regular
determination of prothrombin time.
Regular determinations of prothrombin time response
should be performed to guide in the initial and subsequent
administration of Pala-Tech Vitamin K1 Chewable Tablets. The dosage
should be adjusted accordingly. The smallest effective dose should be
sought to minimize the risk of adverse reactions.
Vitamin K 25 mg is for dogs and cats.
Vitamin K 50 mg is for use in dogs only.
Administration: Each tablet,
Pala-Tech Vitamin K1 Chewable Tablets, may be given orally to dogs &
cats as a
treat, or crumbled over their food. If crumbled over food, consumption
should be monitored.
100% PALATABILITY ACCEPTANCE
Composition: Each scored, round,
chewable tablet contains 50 mg of phytonadione in a proprietary, highly
palatable roast beef and liver flavor base.
Cautions: Temporary resistance to
prothrombin-depressing anticoagulants may result, especially when larger
doses of phytonadione are used. It is recommended that Pala-Tech
Vitamin K1 Chewable Tablets be used in follow-up therapy only after
administration of Vitamin K1 injection and hospitalization is no longer
required. An immediate coagulant effect should not be expected after
administration of phytonadione when administered orally.
Phytonadione will not counteract the anticoagulant
action of heparin. Repeated large doses of Vitamin K1 are not warranted
in hepatic disease if the response to the initial therapy is
unsatisfactory. Failure to respond to Vitamin K1 may indicate that the
condition being treated is inherently unresponsive to Vitamin K1.
KEEP OUT OF REACH OF CHILDREN
Store at controlled room temperature; 15° C-30° C (59°
F-86° F) and protect from light. Dispense in this container or another
tight, light-resistant container.
